New drug offers hope for chronic nerve pain without risk of addiction

Credit: Unsplash+

Millions of people around the world suffer from chronic nerve pain, also known as neuropathic pain. This type of pain happens when nerves outside the brain are damaged. It can be sharp, burning, or tingling, and often lasts for months or even years. Living with nerve pain can make everyday tasks difficult and seriously affect quality of life.

Treating this condition has always been a challenge. Doctors usually prescribe medicines like gabapentin or duloxetine—drugs originally made to treat epilepsy and depression. These can help some people, but not everyone gets relief. They can also cause side effects like dizziness, tiredness, and mood changes.

Opioids, another kind of pain medicine, can also be used, but they are risky. Opioids can cause addiction, overdose, and even death if misused. Because of these problems, scientists have been working hard to find a safer and more effective way to treat nerve pain.

Now, researchers at Weill Cornell Medicine and the Burke Neurological Institute may have found a solution. They have developed a new drug that could ease nerve pain without the dangerous side effects of current treatments. The drug is called BP4L-18:1:1, and it works in a brand-new way.

The idea for this drug came from a surprising link between pain research and ocean science. Scientists learned that nerve pain is tied to certain proteins in the body called HCN ion channels. These channels help control how nerves send signals.

But when they become too active, they can send constant pain signals—even when there is no injury. Blocking these channels could reduce pain, but the problem is that HCN channels also exist in the brain and heart. Blocking them everywhere could cause serious issues like heart trouble or extreme sleepiness.

To solve this, Dr. Gareth Tibbs and his team came up with a clever plan. They took a commonly used surgical drug called propofol and changed its structure. Then they added a special chemical anchor that keeps the drug outside the brain. This means it can calm the overactive nerve cells that cause pain without affecting the heart or brain.

Imagine it like tying a boat to the shore. The boat can still float in the water, but it won’t drift away. In the same way, this chemical anchor keeps the drug in the right part of the body—where it’s needed—and keeps it from going where it might cause harm.

When the drug was tested in rats, it significantly reduced nerve pain. Even better, the drug was given as a pill, not an injection, and it didn’t cause any noticeable side effects. This makes it very different from other painkillers, especially opioids.

The research team is now preparing for human clinical trials. If the drug proves safe and effective in people, it could become a new way to treat chronic nerve pain—without the risks of addiction or other serious side effects.

Dr. Steven Fox, founder of Akelos, the company helping to develop this drug, said, “This new drug has the potential to change how we treat chronic nerve pain. It targets the root cause without harmful side effects.”

The work was supported by the Daedalus Fund for Innovation, which helps turn lab discoveries into real-world treatments.

If all goes well, this drug could bring real hope to the millions who struggle every day with nerve pain. It may offer a new path to relief, allowing people to live more comfortably and safely—without depending on opioids or suffering through ineffective treatments.

If you care about pain, please read studies about how to manage gout with a low-purine diet, and a guide to eating right for arthritis.

For more health information, please see recent studies about the link between processed foods and chronic diseases, and avoid these 8 foods to ease arthritis pain.

Copyright © 2025 Knowridge Science Report. All rights reserved.